Funding search · EIN 042103547 · Boston, MA

Trustees of Boston University

A grantmaking public charity (files IRS Form 990, Schedule I). Charities like this often run real grant programs with application cycles.

1,097
grants reported
$445.0M
total given
2021–2024
filing years
$115,559
median grant

Based on grants this organization reported to the IRS for tax years 20212024. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.

What they fund

research

Funder website ↗Full IRS filings ↗How this is builtReport an error

Funding pattern

What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.

Where the money goes

  • Antibacterial and antifungal drug developers, mostly small biotech companies
  • Rapid infectious-disease diagnostics firms (Visby, Avails, Day Zero, Pearl)
  • Boston teaching hospitals: MGH, Boston Medical Center, Brigham, BIDMC
  • Multi-site university subawards on clinical and translational studies
  • Phage therapy and microbiome therapeutics (Locus, Vedanta)
  • Global health delivery partners such as CHAI and JSI

Typical grant

Median is $115,559, with the middle half between $34,317 and $339,482, so most of the file is ordinary subaward-scale money. The checks above $2 million go almost entirely to antibacterial and diagnostics companies (Day Zero $5.3M, Cellics $5.0M, Locus $3.8M, Visby $3.6M) plus MGH and Harvard; the small ones are academic sites on multi-center studies. With 1,097 payments to 683 recipients across four years, renewal across years is the norm rather than the exception.

Their words

Phrases from their own grant descriptions, worth speaking back to them.

  • RESEARCH
  • INC
  • REGENTS OF THE UNIVERSITY OF
  • BOARD OF TRUSTEES OF

Positioning adjacent work

  • Treat this as subaward flow, not philanthropy. Find the BU prime-award PI, not a program officer.
  • Anchor to drug-resistant bacterial infection: therapeutics, phage, or point-of-care diagnostics. That is where the largest checks sit.
  • Ask in the $50K to $350K range as a site or core; multimillion asks go to product developers.
  • If you run a clinical site or assay core, pitch enrollment capacity or a validated readout, not novel discovery.

Worth knowing: This is a university's outbound research money, so the pattern is relationship-driven through BU faculty and existing consortium structures rather than open review. Massachusetts takes 249 of 1,097 grants, and the presence of dozens of for-profit biotech recipients points to an antibacterial accelerator portfolio absorbing most of the large-dollar giving.

4 grants matching “fitzgerald · $40,000

  • $10,000

    Rose Fitzgerald Kennedy Greenway Conservancy · Boston, MA · 2024

    Charitable donation

  • $10,000

    Rose Fitzgerald Kennedy Greenway Conservancy · Boston, MA · 2023

    Charitable donation

  • $10,000

    Rose Fitzgerald Kennedy Greenway Conservancy · Boston, MA · 2022

    Research Charitable donation

  • $10,000

    Rose Fitzgerald Kennedy Greenway Conservancy · Boston, MA · 2021

    Charitable donation

Top recipients

Repeat recipients are the strongest signal of whether a funder has an open door or quietly re-funds the same organizations.

  • Pattern Bioscience2 grants · $11.4M
  • The General Hospital Corporation2 grants · $10.6M
  • Day Zero Diagnostics2 grants · $10.1M
  • Peptilogics2 grants · $8.4M
  • The General Hospital Corporation2 grants · $7.9M
  • President & Fellows of Harvard Coll2 grants · $7.5M
  • Day Zero Diagnostics2 grants · $7.2M
  • Clarametyx Biosciences2 grants · $6.8M
  • Glaxosmithkline Holdings Americas1 grant · $6.2M
  • Cellics Therapeutics2 grants · $5.8M

Giving over time

$136.9M
2021
$106.3M
2022
$92.0M
2023
$109.8M
2024

Grant history

The 100 largest of 1,097 grants.

  • $8.0M

    Pattern Bioscience · Austin, TX · 2021

    Research

  • $6.9M

    Day Zero Diagnostics · Boston, MA · 2022

    Research Research

  • $6.2M

    Glaxosmithkline Holdings Americas · Philadelphia, PA · 2021

    Research

  • $5.5M

    Clarametyx Biosciences · Columbus, OH · 2021

    Research

  • $5.5M

    The General Hospital Corporation · Boston, MA · 2023

    Research

  • $5.4M

    The General Hospital Corporation · Boston, MA · 2022

    Research Research

  • $5.3M

    Day Zero Diagnostics · Boston, MA · 2024

    Research

  • $5.1M

    The General Hospital Corporation · Boston, MA · 2024

    Research

  • $5.0M

    Cellics Therapeutics · San Diego, CA · 2024

    Research

  • $4.8M

    Peptilogics · Pittsburgh, PA · 2021

    Research

  • $4.4M

    President & Fellows of Harvard Coll · Boston, MA · 2024

    Research

  • $3.8M

    Avails Medical · Menlo Park, CA · 2022

    Research Research

  • $3.8M

    Locus Biosciences · Morrisville, NC · 2024

    Research

  • $3.6M

    Peptilogics · Pittsburgh, PA · 2022

    Research Research

  • $3.6M

    Visby Medical · San Jose, CA · 2024

    Research

  • $3.6M

    Amicrobe · Carlsbad, CA · 2021

    Research

  • $3.4M

    Pattern Bioscience · Austin, TX · 2022

    Research Research

  • $3.4M

    Vaxcyte · San Carlos, CA · 2022

    Research Research

  • $3.4M

    Regents Univ of Ca Los Angeles · Los Angeles, CA · 2023

    Research

  • $3.3M

    Affinivax · Cambridge, MA · 2021

    Research

  • $3.3M

    Massachusetts Institute of Technoloy · Cambridge, MA · 2023

    Research

  • $3.2M

    Day Zero Diagnostics · Boston, MA · 2021

    Research

  • $3.1M

    Contrafect Corp · Yonkers, NY · 2021

    Research

  • $3.1M

    President & Fellows of Harvard Coll · Boston, MA · 2023

    Research

  • $3.1M

    Avails Medical · Menlo Park, CA · 2023

    Research

  • $3.0M

    Boston Medical Center · Boston, MA · 2024

    Research

  • $2.9M

    Integrated Biotherapeutics · Rockville, MD · 2021

    Research

  • $2.9M

    Regents Univ of Ca Los Angeles · Los Angeles, CA · 2022

    Research Research

  • $2.9M

    Lumen Bioscience · Seattle, WA · 2022

    Research Research

  • $2.9M

    Boston Medical Center Corporation · Boston, MA · 2023

    Research

  • $2.8M

    Vaxcyte · San Carlos, CA · 2023

    Research

  • $2.7M

    Avails Medical · Menlo Park, CA · 2024

    Research

  • $2.6M

    Entasis Therapeutics · Waltham, MA · 2021

    Research

  • $2.5M

    The Regents of the University of Ca · Los Angeles, CA · 2023

    Research

  • $2.5M

    Micurx Pharmaceuticals · Palo Alto, CA · 2021

    Research

  • $2.5M

    The General Hospital Corporation · Boston, MA · 2021

    Research

  • $2.4M

    Regents Univ of Ca Los Angeles · Los Angeles, CA · 2024

    Research

  • $2.4M

    Lumen Bioscience · Seattle, WA · 2021

    Research

  • $2.4M

    Microbion Corporation · Bozeman, MT · 2021

    Research

  • $2.3M

    Boston Medical Center · Boston, MA · 2021

    Research

  • $2.2M

    Cellics Therapeutics · San Diego, CA · 2021

    Research

  • $2.2M

    Massachusetts Institute of Technolo · Cambridge, MA · 2022

    Research Research

  • $2.2M

    The Regents of the University of Ca · Los Angeles, CA · 2024

    Research

  • $2.2M

    University Corporation for Atmospheric · Birmingham, AL · 2021

    Research

  • $2.1M

    Baebies · Durham, NC · 2022

    Research Research

  • $2.1M

    The Regents of the University of Ca · Los Angeles, CA · 2022

    Research Research

  • $2.1M

    The Regents of the University of Mi · Pittsburgh, PA · 2023

    Research

  • $2.0M

    Boston Medical Center · Boston, MA · 2022

    Research Research

  • $2.0M

    Amicrobe · Carlsbad, CA · 2022

    Research Research

  • $2.0M

    Regents Univ of Ca Los Angeles · Los Angeles, CA · 2021

    Research

  • $2.0M

    Locus Biosciences · Morrisville, NC · 2023

    Research

  • $2.0M

    Vedanta Biosciences · Cambridge, MA · 2022

    Research Research

  • $2.0M

    Regents of the University of Califo · Los Angeles, CA · 2024

    Research

  • $2.0M

    Vanderbilt University · Dallas, TX · 2024

    Research

  • $2.0M

    Massachusetts Institute of Technolo · Cambridge, MA · 2024

    Research

  • $2.0M

    University of Alabama at Birmingham · Birmingham, AL · 2024

    Research

  • $2.0M

    University of Massachusetts · North Dartmouth, MA · 2024

    Research

  • $1.9M

    Vedanta Biosciences · Cambridge, MA · 2024

    Research

  • $1.9M

    University of Pennsylvania · Philadelphia, PA · 2021

    Research

  • $1.8M

    Day Zero Diagnostics · Boston, MA · 2023

    Research

  • $1.8M

    President & Fellows of Harvard Coll · Boston, MA · 2022

    Research Research

  • $1.8M

    Massachusetts Institute of Technologt · Cambridge, MA · 2021

    Research

  • $1.8M

    The Regents of the University of Mi · Ann Arbor, MI · 2021

    Research

  • $1.8M

    The Regents of the University of Mi · Pittsburgh, PA · 2024

    Research

  • $1.8M

    Trellis Bioscience · Redwood City, CA · 2021

    Research

  • $1.7M

    The Broad Institute · Cambridge, MA · 2024

    Research

  • $1.7M

    President & Fellows of Harvard College · Boston, MA · 2021

    Research

  • $1.7M

    The University of Iowa · Iowa City, IA · 2024

    Research

  • $1.7M

    Vedanta Biosciences · Cambridge, MA · 2021

    Research

  • $1.7M

    Novel Microdevices · Baltimore, MD · 2021

    Research

  • $1.6M

    Regents of the University of California · Los Angeles, CA · 2021

    Research

  • $1.6M

    Locus Biosciences · Morrisville, NC · 2021

    Research

  • $1.6M

    Vaxcyte · San Carlos, CA · 2021

    Research

  • $1.6M

    Trellis Bioscience · Redwood City, CA · 2022

    Research Research

  • $1.6M

    The Brigham & Womens Hospital · Boston, MA · 2021

    Research

  • $1.6M

    American College of Radiology · Reston, VA · 2021

    Research

  • $1.6M

    Avails Medical · Menlo Park, CA · 2021

    Research

  • $1.6M

    Helixbind · Marlborough, MA · 2021

    Research

  • $1.5M

    Yeshiva University · Bronx, NY · 2022

    Research Research

  • $1.4M

    Baebies · Durham, NC · 2021

    Research

  • $1.4M

    State of Maryland · College Park, MD · 2024

    Research

  • $1.4M

    Bugworks Research · Fremont, CA · 2021

    Research

  • $1.4M

    Beth Israel Deaconess Medical Cente · Boston, MA · 2024

    Research

  • $1.4M

    Beth Israel Deaconess Medical Cente · Boston, MA · 2023

    Research

  • $1.4M

    Integrated Biotherapeutics · Rockville, MD · 2022

    Research Research

  • $1.4M

    Macro Biologics · Carlsbad, CA · 2024

    Research

  • $1.4M

    Vedanta Biosciences · Cambridge, MA · 2023

    Research

  • $1.4M

    Clinton Health Access Initiative in · Boston, MA · 2024

    Research

  • $1.3M

    The University of Iowa · Iowa City, IA · 2023

    Research

  • $1.3M

    Rector and Visitors of the Univ of · Charlottesville, VA · 2021

    Research

  • $1.3M

    The Regents of the University of Mi · Pittsburgh, PA · 2022

    Research Research

  • $1.3M

    University of Washington · Chicago, IL · 2022

    Research Research

  • $1.3M

    The Brigham & Womens Hospital · Boston, MA · 2023

    Research

  • $1.3M

    The Trustees of Columbia University · New York, NY · 2023

    Research

  • $1.3M

    Venatorx Pharmaceuticals · Malvern, PA · 2021

    Research

  • $1.3M

    University of Alabama at Birmingham · Birmingham, AL · 2022

    Research Research

  • $1.3M

    Clarametyx Biosciences · Columbus, OH · 2022

    Research Research

  • $1.3M

    Lytica Therapeutics · Boston, MA · 2021

    Research

  • $1.3M

    Novel Microdevices Llc · Baltimore, MD · 2021

    Research

  • $1.2M

    University of Alabama at Birmingham · Birmingham, AL · 2023

    Research

View all 1,097 grants →

Who else funds this kind of work

Same state

Similar purposes

Similar grant size

Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.

Search funders like this one

Source: IRS Form 990, Schedule I, as filed by this organization. These are grants already paid. Grants paid directly to individuals are reported to the IRS only as totals, so they do not appear as named lines here.